Literature DB >> 15567754

The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.

Mei Xiao1, Nin-Xing Zhou, Zhi-Qiang Huang, Ya-Li Lu, Ling-Hong Chen, Dian-Jun Wang, Wei-Lin Chang.   

Abstract

BACKGROUND: Hilar cholangiocarcinoma is associated with low resectability and poor survival. The aim of this study was to evaluate the roles of matrix metalloproteinases-2 (MMP-2) and its tissue inhibitor of metalloproteinase-2(TIMP-2) in tumor invasion or as a prognostic factor in patients with human hilar cholangiocarcinoma.
METHODS: The expressions of MMP-2 and TIMP-2 were investigated in patients. Paraffinized tissue sections obtained from 50 patients with human hilar cholangiocarcinoma were analysed. The expressions of MMP-2 and TIMP-2 were examined immunohistochemically. Image analysis with image-pro plus analysis software was used to semiquantitatively determine the ratio of MMP-2 to TIMP-2.
RESULTS: The expression levels of MMP-2 and TIMP-2 were strongly associated with tumor hepatic invasion in patients with hilar cholangiocarcinoma. Significant differences in the ratio of MMP-2 to TIMP-2 between some pathologic factors were observed in patients with hilar cholangiocarcinoma.
CONCLUSIONS: MMP-2 plays an essential role in tumor invasion and metastasis, while TIMP-2 is shown to strongly inhibit cancer invasion and metastasis. The ratio of MMP-2 to TIMP-2 may be a prognostic indicator for patients with hilar cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15567754

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  2 in total

1.  CD24 expression is an independent prognostic marker in cholangiocarcinoma.

Authors:  Shefali Agrawal; Boris W Kuvshinoff; Thaer Khoury; Jihnhee Yu; Milind M Javle; Charles LeVea; Jeff Groth; Lionel J Coignet; John F Gibbs
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

2.  Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.

Authors:  Yiqing Li; Yong Zhang; Qichang Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.